These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
752 related items for PubMed ID: 3079724
21. Temporary increase of FSH levels in healthy, nulliparous, young women after cessation of low-dose oral contraceptive use. Jernstrom H, Knutsson M, Olsson H. Contraception; 1995 Jul; 52(1):51-6. PubMed ID: 8521715 [Abstract] [Full Text] [Related]
22. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment]. Bayard F, Louvet JP, Moatti JP, Smilovici W, Duguet L, Boulard C. J Gynecol Obstet Biol Reprod (Paris); 1975 Jul; 4(7):915-26. PubMed ID: 767402 [Abstract] [Full Text] [Related]
23. Regional gray matter volume differences and sex-hormone correlations as a function of menstrual cycle phase and hormonal contraceptives use. De Bondt T, Jacquemyn Y, Van Hecke W, Sijbers J, Sunaert S, Parizel PM. Brain Res; 2013 Sep 12; 1530():22-31. PubMed ID: 23892107 [Abstract] [Full Text] [Related]
27. Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels. Sehested A, Juul AA, Andersson AM, Petersen JH, Jensen TK, Müller J, Skakkebaek NE. J Clin Endocrinol Metab; 2000 Apr 12; 85(4):1634-40. PubMed ID: 10770209 [Abstract] [Full Text] [Related]
28. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome. Eriksson E, Alling C, Andersch B, Andersson K, Berggren U. Neuropsychopharmacology; 1994 Nov 12; 11(3):201-13. PubMed ID: 7532413 [Abstract] [Full Text] [Related]
29. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486. Liu JH, Garzo G, Morris S, Stuenkel C, Ulmann A, Yen SS. J Clin Endocrinol Metab; 1987 Dec 12; 65(6):1135-40. PubMed ID: 2824550 [Abstract] [Full Text] [Related]
30. Effect of daily administration of 0.5 mg. of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone, and progesterone during the menstrual cycle. Saunders DM, Marcus SL, Saxena BB, Beling CG, Connell EB. Fertil Steril; 1971 May 12; 22(5):332-44. PubMed ID: 4102481 [Abstract] [Full Text] [Related]
32. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control? Nillius SJ, Bergquist C, Wide L. Contraception; 1978 Jun 12; 17(6):537-45. PubMed ID: 352612 [Abstract] [Full Text] [Related]
34. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation. Croxatto HB, Salvatierra AM, Romero C, Spitz IM. J Clin Endocrinol Metab; 1987 Dec 12; 65(6):1272-7. PubMed ID: 3119656 [Abstract] [Full Text] [Related]
35. Lack of impact of pharmacological growth hormone administration on circulating levels of reproductive hormones during the menstrual cycle in normal women. Ovesen P, Møller J, Jørgensen JO, Møller N, Christiansen JS. Fertil Steril; 1993 Feb 12; 59(2):311-4. PubMed ID: 8425624 [Abstract] [Full Text] [Related]
36. Modulation of immunoreactive somatomedin-C levels by sex steroids. Caufriez A, Golstein J, Tadjerouni A, Bosson D, Cantraine F, Robyn C, Copinschi G. Acta Endocrinol (Copenh); 1986 Jun 12; 112(2):284-9. PubMed ID: 2943106 [Abstract] [Full Text] [Related]
38. Comparison of the patterns of androstenedione, progesterone, and estradiol during the human menstrual cycle. Ribeiro WO, Mishell DR, Thorneycroft IH. Am J Obstet Gynecol; 1974 Aug 15; 119(8):1026-32. PubMed ID: 4847439 [Abstract] [Full Text] [Related]